CCNG2
Basic information
Region (hg38): 4:77157207-77433388
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCNG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 4 |
Variants in CCNG2
This is a list of pathogenic ClinVar variants found in the CCNG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-77158566-C-G | not specified | Uncertain significance (Nov 17, 2023) | ||
4-77158568-T-A | not specified | Uncertain significance (Dec 14, 2023) | ||
4-77158583-T-C | Benign (Aug 16, 2018) | |||
4-77158584-C-A | not specified | Uncertain significance (Apr 13, 2022) | ||
4-77158615-A-G | Benign (Apr 04, 2018) | |||
4-77159485-G-C | not specified | Uncertain significance (May 09, 2022) | ||
4-77160839-A-G | not specified | Uncertain significance (Feb 07, 2023) | ||
4-77160852-T-C | Benign (Aug 16, 2018) | |||
4-77160943-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
4-77160944-C-G | not specified | Uncertain significance (Mar 28, 2023) | ||
4-77161495-C-A | not specified | Uncertain significance (Sep 13, 2023) | ||
4-77161668-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
4-77161721-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
4-77164274-A-G | not specified | Likely benign (Jun 25, 2024) | ||
4-77164319-T-C | not specified | Uncertain significance (Jan 10, 2023) | ||
4-77164323-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
4-77164408-C-T | Benign (Oct 10, 2018) | |||
4-77165821-T-A | not specified | Uncertain significance (Nov 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCNG2 | protein_coding | protein_coding | ENST00000316355 | 7 | 276239 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00969 | 0.981 | 125728 | 0 | 20 | 125748 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.669 | 147 | 172 | 0.856 | 0.00000813 | 2260 |
Missense in Polyphen | 20 | 38.152 | 0.52422 | 514 | ||
Synonymous | -0.588 | 69 | 63.1 | 1.09 | 0.00000296 | 629 |
Loss of Function | 2.26 | 6 | 15.7 | 0.383 | 7.42e-7 | 220 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000490 | 0.000486 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000140 | 0.000139 |
European (Non-Finnish) | 0.0000530 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000427 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in growth regulation and in negative regulation of cell cycle progression.;
- Pathway
- p53 signaling pathway - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);G1 to S cell cycle control;DNA Damage Response (only ATM dependent)
(Consensus)
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- loftool
- 0.606
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.21
Haploinsufficiency Scores
- pHI
- 0.333
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.512
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.805
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccng2
- Phenotype
Gene ontology
- Biological process
- regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle;protein phosphorylation;regulation of mitotic nuclear division;positive regulation of cell population proliferation;positive regulation of cell cycle;cell division
- Cellular component
- cyclin-dependent protein kinase holoenzyme complex;nucleus;cytoplasm
- Molecular function
- protein kinase activity;cyclin-dependent protein serine/threonine kinase regulator activity;protein kinase binding